The Strategic Allocation Framework (SAF) reflects a refined vision to ensure that CIRM’s investments are aligned with its mission.

South San Francisco, CA, May 29, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, awarded $4.7 million to ...

The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a ...

This TRAN1 award helped to fund the development of Siren Biotechnology’s lead therapy, SRN-101, for high-grade glioma brain cancers in patients. In this reporting period, we completed the final ...

在哺乳动物早期细胞分化过程中，代谢调控着细胞命运。本方案描述了使用化学成分明确的营养平衡培养基配方，将已启动的人类多能干细胞 (hPSC) 定向分化为三个主要生殖细胞谱系——外胚层 ...

Shared Labs Grant – Establishing SRLs Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center Stem cell-based Parternship Resource for Investigating Human Diseases and Training ...

Severe Combined Immunodeficiency (SCID) is a rare primary immunodeficiency in which patients lack T and B cells, the white blood cells needed to fight infections. Without a bone marrow stem cell ...

Late Stage Preclinical Projects Aaron Nagiel Development of a novel intravitreal AAV gene therapy for the rare disease blue cone monochromacy. $4,691,936 Get the latest CIRM news, information on ...

We are deeply saddened to learn of the passing of a subject enrolled in Rocket Pharmaceuticals’ Phase 2 clinical trial of RP-A501 to treat Danon disease. On behalf of the California Institute for ...

极低频低强度电磁场 (ELF-EMF) 疗法是一种非侵入性脑刺激方法，可以调节神经保护和神经可塑性。最近的一项小规模试点临床试验 (NCT04039178) 表明，ELF-EMF 可以促进人类中风的恢复。ELF-EMF 的频率 ...

The use of stem cell technology to study neurodegenerative diseases has been a burgeoning area of research in recent years. Recent work by us and others have demonstrated that stem cell derived ...